Acceptability and continuation of use of the subdermal contraceptive implant among adolescents and young women in Argentina: a retrospective cohort study.


Journal

Sexual and reproductive health matters
ISSN: 2641-0397
Titre abrégé: Sex Reprod Health Matters
Pays: England
ID NLM: 101743493

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 14 4 2023
entrez: 12 4 2023
pubmed: 13 4 2023
Statut: ppublish

Résumé

A new public policy was instituted in Argentina for free distribution of subdermal contraceptive implants to women aged 15-24 years old in the public healthcare system. The objective of this study is to determine the extent to which this population adhered to the implant, as well as predictors of continuation. The retrospective cohort study was based on a telephone survey of a random sample of 1101 Ministry of Health-registered implant users concerning the continuation of use, satisfaction with the method and side-effects, and reasons for removal. Descriptive statistics and multivariate regression analysis were used to explore the association between adherence and having received contraceptive counselling, satisfaction, and side effects. We found high levels of adherence (87%) and satisfaction (94%). Common reported side effects were amenorrhoea or infrequent bleeding, perceived weight gain, increased menstrual bleeding and headaches. Multivariate regression analysis indicates that, among adolescents, having received contraceptive counselling increased comfort, while frequent bleeding at six months hindered trust. Participants who had a history of a prior delivery or who had themselves primarily chosen the method were less likely to request the removal of the implant. Our results support the public policy of free implant distribution in the public health sector. This is a sustainable public policy that contributes to equity and access to effective contraception. It is appropriate for adolescents and young women and will also reduce unintended pregnancies. Our results suggest that counselling patients is key prior to insertion of the implant, as it improves acceptability and continuation.

Identifiants

pubmed: 37042700
doi: 10.1080/26410397.2023.2189507
pmc: PMC10101666
doi:

Substances chimiques

Levonorgestrel 5W7SIA7YZW
Contraceptive Agents, Female 0
Drug Implants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2189507

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

N Engl J Med. 2017 Feb 2;376(5):461-468
pubmed: 28146650
Am J Obstet Gynecol. 2017 Apr;216(4):364.e1-364.e12
pubmed: 28038902
Contraception. 2014 Jun;89(6):578-83
pubmed: 24656553
Contraception. 2014 Nov;90(5):522-8
pubmed: 24973905
Clin Obstet Gynecol. 2014 Dec;57(4):635-43
pubmed: 25286295
Eur J Contracept Reprod Health Care. 2016 Jun;21(3):213-9
pubmed: 26848851
Fam Plann Perspect. 1996 Nov-Dec;28(6):256-60
pubmed: 8959415
Am J Obstet Gynecol. 2016 Jun;214(6):681-8
pubmed: 26875950
Obstet Gynecol. 2017 Nov;130(5):e251-e269
pubmed: 29064972
Hum Reprod. 2015 Nov;30(11):2527-38
pubmed: 26409014
Contraception. 2009 Dec;80(6):527-32
pubmed: 19913146
Lancet Glob Health. 2019 Feb;7(2):e227-e235
pubmed: 30683240
Perspect Sex Reprod Health. 2014 Sep;46(3):125-32
pubmed: 24961366
Hum Reprod Open. 2018 Jan 23;2018(1):hox030
pubmed: 30895242
Hum Reprod. 2014 Oct 10;29(10):2163-70
pubmed: 25085802
Int Perspect Sex Reprod Health. 2020 Dec 14;46(Suppl 1):35-43
pubmed: 33326398
Clin Ther. 1996 Jan-Feb;18(1):150-9
pubmed: 8851460
Matern Child Health J. 2017 Sep;21(9):1724-1733
pubmed: 27150948
Eur J Contracept Reprod Health Care. 2011 Jun;16(3):225-8
pubmed: 21395387
Hum Reprod. 2014 Jul;29(7):1393-9
pubmed: 24812309

Auteurs

Daniel Maceira (D)

Professor, Department of Economics; Universidad de Buenos Aires, and Independent Researcher, National Council of Scientific and Technical Research (CONICET), Buenos Aires, Argentina.
Senior Researcher, Center for the Study of State and Society (CEDES), Buenos Aires, Argentina.
Board Member and Chair for The Americas, Health Systems Global (HSG). Correspondence: danielmaceira@cedes.org.

Silvia Oizerovich (S)

Professor, Faculty of Medical Sciences, Universidad Favaloro, Buenos Aires, Argentina.
President of the Ibero-American Network of Sexual and Reproductive Health Professionals, Buenos Aires, Argentina.
Member of the Scientific Committee of the Argentinian Pediatric and Adolescent Gynecology Society (SAGIJ) and Argentinian Medical Association for Contraception (AMAdA), Buenos Aires, Argentina.

Gabriela Perrotta (G)

Member of the Scientific Committee of the Argentinian Pediatric and Adolescent Gynecology Society (SAGIJ) and Argentinian Medical Association for Contraception (AMAdA), Buenos Aires, Argentina.
Professor, Faculty of Psychology, Universidad de Buenos Aires, Buenos Aires, Argentina.

Rodolfo Gómez Ponce de León (RGP)

Sexual and Reproductive Health Regional Advisor at Pan-American Health Organization / World Health Organization (PAHO/WHO), Latin-American Center of Perinatology and Women's Health (PAHO/CLAP), Montevideo, Uruguay.
Adjunct Professor School of Public Health of the University of North Carolina, Chapel Hill, NC, USA.

Ariel Karolinski (A)

Advisor, Family, Health Promotion and Life Course; Coordinator of Family, Gender and Life Course, Pan-American Health Organization/World Health Organization (PAHO/WHO), Brasilia, Brazil Representation.

Natalia Suarez (N)

Professor, Universidad Nacional de Hurlingham, Community Health Institute, Buenos Aires, Argentina.

Natalia Espinola (N)

Teaching Assistant Professor, Department of Economics, University of Buenos Aires, Buenos Aires, Argentina.

Sonja Caffe (S)

Regional Advisor on Adolescent Health, Healthy Life Course Family, Health Promotion and Life Course PAHO/WHO, Washington, DC, USA.

Venkatraman Chandra-Mouli (V)

Scientist, Adolescent Sexual and Reproductive Health, UNDP/UNFPA/UNICEF/WHO/World Bank Special Program of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH